IMS: merger with TPG/CPPIB on track

Share this article:
IMS Health convened a special meeting to vote on its buyout offer, in what some consider a move to restore investor confidence in the deal.

At the Feb. 8 meeting, stockholders will be entitled to vote on the buyout. At press time, an IMS spokesman told MM&M that the final proxy was filed with SEC on Dec. 29, and that the company still believes the transaction will be completed by the end of the first quarter.

IMS shares plunged in December after reports swirled of a possible congressional amendment banning the collection of physicians' prescribing data for marketing purposes, a proposal which analysts said may have imperiled IMS's buyout deal.

The planned takeover by investment funds TPG Capital and CPP Investment Board, announced in November, is valued at $5.2 billion, including assumed debt.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?